$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
吉妥单抗获FDA批准用于CD33阳性急性髓性白血病
2025-10-19 11:44:20
Check Details
阿卡替尼是一款可用于治疗慢性淋巴细胞白血病的BTK抑制剂
2025-10-19 11:44:20
Check Details
第二代BTK抑制剂阿卡替尼的禁忌和用药注意事项
2025-10-19 11:44:20
Check Details
慢性淋巴细胞白血病(CLL)使用阿卡替尼治疗的效果
2025-10-19 11:44:20
Check Details
全球仅获批上市的2款BTK抑制剂-伊布替尼和阿卡替尼
2025-10-19 11:44:20
Check Details
AMG 716联合吉列替尼对FLT3-ITD+AML具有良好的临床前活性
2025-10-19 11:44:20
Check Details
奈拉宾对急性T细胞淋巴母细胞性白血病有着不错的效果
2025-10-19 11:44:20
Check Details
艾伏尼布多少钱一瓶?国内能买到吗?
2025-10-19 11:44:20
Check Details
急性T细胞淋巴母细胞性白血病治疗新药-奈拉宾
2025-10-19 11:44:20
Check Details
艾伏尼布对复发性或难治性急性骨髓性白血病有显著的效果
2025-10-19 11:44:20
Check Details
用奈拉宾治疗急性T细胞淋巴母细胞性白血病取得了较好的疗效
2025-10-19 11:44:20
Check Details
艾伏尼布是用来治疗复发性或难治性急性骨髓性白血病的药物
2025-10-19 11:44:20
Check Details
1
2
...
598
599
600
601
602
603
604
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Avatrombopag (Doptelet): Oral TPO-RA for Multiple Thrombocytopenia Types
2
Gilteritinib (Xospata): Precision Oral Targeted Therapy for FLT3-Mutated AML
3
Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD): Efficacy, Side Effects, and Patient Treatment Guide
4
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
5
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
6
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
7
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
8
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
9
A Key Therapeutic Breakthrough Against T315I-Mutant CML
10
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
11
Tafasitamab and Lenalidomide Combination Therapy Guide
12
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management